Last reviewed · How we verify

amoxicillin and gentamicin

Aga Khan University · Phase 3 active Small molecule

Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis in bacteria, while gentamicin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis.

Amoxicillin is a beta-lactam antibiotic that inhibits cell wall synthesis in bacteria, while gentamicin is an aminoglycoside antibiotic that interferes with bacterial protein synthesis. Used for Community-acquired pneumonia, Skin and skin structure infections.

At a glance

Generic nameamoxicillin and gentamicin
SponsorAga Khan University
Drug classBeta-lactam antibiotic, Aminoglycoside antibiotic
TargetPenicillin-binding proteins, 30S ribosomal subunit
ModalitySmall molecule
Therapeutic areaInfectious diseases
PhasePhase 3

Mechanism of action

Amoxicillin works by binding to penicillin-binding proteins on the bacterial cell wall, preventing the formation of a functional cell wall and ultimately leading to cell lysis and death. Gentamicin, on the other hand, binds to the 30S subunit of the bacterial ribosome, interfering with protein synthesis and ultimately leading to bacterial death.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: